Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

CHEMOURS Aktie

 >CHEMOURS Aktienkurs 
11.105 EUR    +3.3%    (Tradegate)
Ask: 11.105 EUR / 298 Stück
Bid: 10.935 EUR / 302 Stück
Tagesumsatz: 702 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
CHEMOURS Aktie über LYNX handeln
>CHEMOURS Performance
1 Woche: +12,5%
1 Monat: -6,7%
3 Monate: -16,2%
6 Monate: +22,3%
1 Jahr: -46,4%
laufendes Jahr: -31,3%
>CHEMOURS Aktie
Name:  CHEMOURS CO. DL-,01
Land:  USA
Sektor:  Chemie
ISIN/ Wkn:  US1638511089 / A14RPH
Symbol/ Ticker:  2CU (Frankfurt) / CC (NYSE)
Kürzel:  FRA:2CU, ETR:2CU, 2CU:GR, NYSE:CC
Index:  -
Webseite:  https://www.chemours.com/
Profil:  Chemours Co. is a leading global provider of perfo..
>Volltext..
Marktkapitalisierung:  1652.9 Mio. EUR
Unternehmenswert:  4893.42 Mio. EUR
Umsatz:  5062.72 Mio. EUR
EBITDA:  615.6 Mio. EUR
Nettogewinn:  -287.11 Mio. EUR
Gewinn je Aktie:  -1.91 EUR
Schulden:  3806.53 Mio. EUR
Liquide Mittel:  528.52 Mio. EUR
Operativer Cashflow:  228.48 Mio. EUR
Bargeldquote:  0.33
Umsatzwachstum:  -3.1%
Gewinnwachstum:  -557.92%
Dividende je Aktie:  0.44 EUR
Dividendenrendite:  5.28%
Dividendenschätzung:  2.74%
Div. Historie:  14.11.25 - 0.07508375€
15.08.25 - 0.075075€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  CHEMOURS
Letzte Datenerhebung:  30.11.25
>CHEMOURS Kennzahlen
Aktien/ Unternehmen:
Aktien: 149.89 Mio. St.
Frei handelbar: 99.25%
Rückkaufquote: -0.05%
Mitarbeiter: 6000
Umsatz/Mitarb.: 0.83 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 29.89%
Bewertung:
KGV: -
KGV lG: 12.91
KUV: 0.29
KBV: 6.46
PEG-Ratio: -
EV/EBITDA: 7.95
Rentabilität:
Bruttomarge: 17.39%
Gewinnmarge: -5.67%
Operative Marge: 6.42%
Managementeffizenz:
Gesamtkaprendite: -4.43%
Eigenkaprendite: -69.74%
>CHEMOURS Peer Group

Es sind 95 Aktien bekannt.
 
30.11.25 - 22:12
This Fund Bought $63 Million of Chemours Stock Even as Shares Sit 80% Below 2017 Highs (Fool)
 
One hedge fund just made a bold bet on a beaten-down chemicals giant—here's what long-term investors should know....
11.11.25 - 14:31
Chemours Q3 Earnings Lag Estimates Amid Operational Disruptions (Zacks)
 
CC posts a Q3 profit rebound with $60M in net income, driven by strong Thermal & Specialized Solutions amid mixed segment results....
07.11.25 - 17:51
Chemours anticipates double-digit Opteon growth and $5.7B–$5.8B sales in 2025 as TSS segment outpaces expectations (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.11.25 - 15:30
Chemours-Aktie fällt nach Verfehlung der Gewinnprognose für Q3 2025/n (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
07.11.25 - 02:30
Chemours (CC) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
 
The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....
07.11.25 - 02:30
Chemours (CC) Q3 Earnings Miss Estimates (Zacks)
 
Chemours (CC) delivered earnings and revenue surprises of -16.67% and +0.19%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...
06.11.25 - 22:36
The Chemours Company Reports Third Quarter 2025 Results (Business Wire)
 
WILMINGTON, Del.--(BUSINESS WIRE)--$CC--The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the third quarter 2025. Key Third Quarter 2025 Results & Highlights1 Net Sales of $1.5 billion were flat compared to the corresponding prior-year quarter, with TSS continuing strong year-over-year growth of 80% in Opteon™ Refrigerants Net Income attributable to Chemours of $60 million, or $0.40 per diluted share, compared with Net Loss attributable to Chemours of $32 million, or $(0.22) per diluted share, in the corresponding prior-year quarter Adjusted Net Income2 of $30 million, or $0.20 per diluted share, compared to $61 million, or $0.40 per diluted share, in the corresponding prior-year quarter Adjusted EBITDA 2,3 of $195 million compared to $202 million in the cor...
05.11.25 - 21:18
Chemours CFO Discusses Growth, Innovation, and Culture On Inside the ICE House Podcast (Accesswire)
 
NORTHAMPTON, MA / ACCESS Newswire / November 5, 2025 / Chemours Chief Financial Officer, Shane Hostetter, was recently featured on the New York Stock Exchange's podcast, Inside the ICE House, a pla......
29.10.25 - 22:03
Chemours Announces Fourth Quarter Dividend (Business Wire)
 
WILMINGTON, Del.--(BUSINESS WIRE)--$CC--The Chemours Company (“Chemours”) (NYSE: CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the fourth quarter of 2025. The dividend will be paid on December 15, 2025, to stockholders of record as of the close of business on November 14, 2025. About The Chemours Company The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers' biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pur...
16.10.25 - 22:33
Chemours Announces Dates for Third Quarter 2025 Earnings Release and Webcast Conference Call (Business Wire)
 
WILMINGTON, Del.--(BUSINESS WIRE)--$CC--The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) today announced that the Company expects to issue its third quarter 2025 financial results after market on Thursday, November 6, 2025. The Company expects to hold its conference call to discuss its third quarter 2025 financial results at 8:00 a.m. Eastern Time on Friday, November 7, 2025. The call is open to the public and can be accessed via the webcast information below. Prior to the Company's conference call, management will post additional prepared financial remarks in the "Events and Presentations" section of the Investor Relations section of Chemours' website at investors.chemours.com. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE: CC) is a global leader in providing industrial and sp...
08.10.25 - 13:42
Chemours′ Trusted Chemistry in Action: Improving Data Center Impact Through Liquid Cooling (Accesswire)
 
NORTHAMPTON, MA / ACCESS Newswire / October 8, 2025 / Data centers operate around the clock, consuming significant amounts of electricity and water for heat management and cooling needs. As rising ......
07.10.25 - 01:00
Luminus Trims Its Hefty Chemours Position (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
24.09.25 - 14:46
Sustainability at Chemours (Accesswire)
 
NORTHAMPTON, MA / ACCESS Newswire / September 24, 2025 / At Chemours, we are committed to making chemistry as responsible as it is essential. Our 2030 Corporate Responsibility Commitment (CRC) goal......
23.09.25 - 21:27
Beyond The Numbers: 4 Analysts Discuss Chemours Stock (Benzinga)
 
Latest Ratings for CC DateFirmActionFromTo Feb 2022RBC CapitalMaintainsOutperform Feb 2022JP MorganMaintainsNeutral Jan 2022UBSMaintainsNeutral View More Analyst Ratings for CC View the Latest Analyst Ratings read more...
10.09.25 - 14:42
Chemours: Delivering Trusted Chemistry: A Year of Progress and Purpose (Accesswire)
 
By Denise Dignam, President & CEO, Chemours NORTHAMPTON, MA / ACCESS Newswire / September 10, 2025 / It has been a pivotal year for Chemours, one marked by significant change and remarkable progres......
03.09.25 - 12:51
Chemours Announces Board Leadership Appointments: Mary Cranston Named Chair, Alister Cowan Named Lead Independent Director (Business Wire)
 
WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) today announced that its Board of Directors has appointed Independent Director Mary Cranston as Chair of the Board and Alister Cowan to the role of Lead Independent Director, effective September 2, 2025. These appointments follow the departure of Dawn Farrell, who has accepted a position with the Canadian government as the Chief Executive Officer of the newly created Major Projects Office under the Building Canada Act. “While Dawn's departure is a loss for Chemours, it is also a moment of pride. Dawn's appointment is a testament to her exceptional leadership and deep commitment to public service,” said Denise Dignam, President and CEO of Chemours. “I welcome the leadership of Mary and Alister in their new roles—continuing the partnership we have established. I am confident that together, we will ensure the successful execution of our Pathway to Thrive strategy.” Cranston, a director since 2015, led Chemours' multi-year B...
20.08.25 - 22:48
Goodbye, Mag 7! These 3 Buy-Rated Small-Cap Stocks Are Starting to Outperform. (Barchart)
 
As investors rotate away from the Magnificent 7, buy-rated small-caps like Chemours, Hillenbrand, and Arrowhead Pharmaceuticals are gaining momentum thanks to smart deals, analyst upgrades, and fresh operational......
14.08.25 - 00:48
Chemours surges to five-month high after cooling fluid qualifies with Samsung SSDs (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
13.08.25 - 00:01
Insiderhandel: President & CEO kauft Aktien von Chemours Co im Wert von 49060 USD (Insiderkauf)
 
Dignam, Denise - Vorstand - Tag der Transaktion: 2025-08-08...
12.08.25 - 17:30
Chemours Q2 Earnings & Revenues Beat Estimates on Higher Volumes (Zacks)
 
CC posts Q2 earnings and sales beat driven by volume and pricing gains, but issues softer sequential guidance....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Frauen machen sich nicht schön, um Männern zu gefallen. Sie tun es, um andere Frauen zu ärgern. - Marcel Aymé
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!